Huadong Medicine Co., Ltd

¥27.72As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000963Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 4.68%
Div yield 3.35%
ROE 13.52%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM 14.14
TSR TTM (30.99%)
Mkt cap ¥48.61B
ROIC 14.62%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥29
6.11%
(15.01%)
Hold 9|3|11|5|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.46
0.48
0.48
0.48
5.71%
16.02%
3.38%
6.12%
Revenue¥B
2.972
3.103
3.182
3.189
9.23%
8.27%
6.92%
6.47%
Peers (US$7.287B)
Cap (US$)
PE
8.673B
17.73x
5.269B
40.09x
Capital
TTM
5Y
10Y
Leveragex
1.087
1.555
1.184
EBIT/Intx
0.188
0.282
0.300
Own earn%
(134.99)
143.48
121.72
Sh yield%
33.98
30.39
31.74
Owners
Insiders/Inst%
5.91
26.87
Short interest%
2.91
SBC / revenue%
1.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
21–32
$1 testx
—
Incr. ROIC%
2